HEXIM-1 AS A TARGET OF LEPTIN SIGNALING TO REGULATE OBESITY AND DIABETES

摘要

Provided are Hexim-1 inhibitor compositions, and methods and kits using said compositions for the treating and regulating obesity and/or diabetes, comprising administering an effective amount of a Hexim-1 inhibitor. Additionally provided are methods for screening for inhibitors of Hexim-1.